Stop TB Partnership’s Global Drug Facility and Otsuka announce a new private-public partnership to expand worldwide access to an MDR-TB drug.

Last updated: 2017-05-05 19:22:14

Efficacy results of Otsuka’s drug for extensively drug-resistant TB (XDR-TB) published in the New England Journal of Medicine.

Last updated: 2017-05-05 19:23:19

The Japanese Ministry of Health, Labour and Welfare approved a medicine developed by Otsuka for treatment of adults with pulmonary MDR-TB.

Last updated: 2017-05-05 19:24:16

Otsuka Wins European Marketing Authorization for a medicine to treat adult pulmonary MDR-TB.

Last updated: 2017-05-05 19:24:52